CDK4 and triple-negative breast carcinoma: In their experiment with a triple-negative breast cancer cell line, they obtained an optimal CDK4 degradation in 4 h and a maximal decomposition of CDK6 in 6 h after treating the cells with 100 nM degrader concentration (Figure 7A) [107].